Prestizia Overview

  • Founded
  • 2011
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 1
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Prestizia General Information

Description

Provider of biotechnology research and development services. The company engages in developing novel diagnostic assays for viral infections and human malignancies based on microRNA expression.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 5 Rue de la Baume
  • 75008 Paris
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Prestizia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Prestizia‘s full profile, request access.

Request a free trial

Prestizia Executive Team (1)

Name Title Board Seat Contact Info
Jean-Jacques Bertrand President
To view Prestizia’s complete executive team members history, request access »

Prestizia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prestizia Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Prestizia‘s full profile, request access.

Request a free trial